Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: VLDL and LDL Particle Types as Coronary Heart Disease Risk Factors
A completed clinical trial evaluated whether VLDL and LDL particle types are coronary heart disease risk factors. The study was sponsored by…
-
CLINICAL_TRIALS research · 2015-01-28Clinical Trial Update: Postoperative Atrial Fibrillation and Long-term Survival
A completed clinical trial update investigating postoperative atrial fibrillation and its association with long-term survival, including out…
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction
The completed trial assessed whether gait speed can predict future cardiovascular events in patients after a myocardial infarction.
-
FDA approval · 2015-01-20FDA Approved: CAPTOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA granted a supplemental approval for CAPTOPRIL (captopril) from Camber Pharmaceuticals, Inc., updating the labeling for an existing capto…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care
The trial update reports that the RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care trial sponsored by Response Biomedical Corp. has…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-01-05FDA Approved: VALSARTAN — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved an Abbreviated New Drug Application for valsartan by Mylan Pharmaceuticals, enabling a generic version of the drug.
-
FDA approval · 2015-01-05FDA Approved: VALSARTAN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for valsartan, a generic ARB. The product is indicated for hypertension, heart fai…
-
FDA approval · 2015-01-05FDA Approved: VALSARTAN — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for valsartan, a generic ARB, for hypertension, heart failure, and reducing cardiov…
-
FDA approval · 2015-01-05FDA Approved: VALSARTAN — Original Application (Aurobindo Pharma Limited)
FDA approves the Original Application for VALSARTAN from Aurobindo Pharma Limited, enabling the generic valsartan product to enter the marke…
-
FDA approval · 2015-01-05FDA Approved: VALSARTAN — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved Jubilant Cadista Pharmacuticals Inc.'s original ANDA for valsartan, a generic angiotensin II receptor blocker. The approval ena…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time [NA]
Completed clinical trial evaluating a pulse wave transit time-based method to estimate cardiac output in patients with myocardial infarction…
-
CLINICAL_TRIALS research · 2014-12-23Clinical Trial Update: Diet Therapy Versus Prescriptive Educational Group Intervention in Overweight / Obese Patients at First Episode of AMI: a Randomized Controlled Trial [NA]
This randomized controlled trial compares diet therapy with a prescriptive educational group intervention in overweight/obese patients at th…
-
FDA approval · 2014-12-19FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)
FDA approved a supplemental application for lisinopril from Solco Healthcare U.S., LLC under the ANDA. The action approves changes to the al…
-
CLINICAL_TRIALS research · 2014-12-17Clinical Trial Update: Evaluation of EarlySense Home Care Tele-monitoring Device [NA]
This clinical trial update covers the EarlySense home care tele-monitoring device in patients with myocardial infarction and after cardiac s…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction [Phase 2]
Phase 2 clinical trial evaluating gadolinium-based MRI contrast (gadobutrol) for depicting delayed enhancement in patients with myocardial i…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Livalo Acute Myocardial Infarction Study (LAMIS)
The Livalo Acute Myocardial Infarction Study (LAMIS) has completed its clinical trial evaluating pitavastatin in patients with acute myocard…
-
FDA approval · 2014-12-11FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)
FDA approved a supplemental application for lisinopril filed by Solco Healthcare U.S., LLC.
-
FDA approval · 2014-12-05FDA Approved: CAPTOPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for captopril from Hikma Pharmaceuticals USA, documenting changes to the marketed captopril product …
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Ferumoxytol for Magnetic Resonance Imaging of Myocardial Infarction [NA]
A study evaluating the use of ferumoxytol for magnetic resonance imaging of myocardial infarction has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol [NA]
The University of Wisconsin's hMSC bone marrow donor protocol trial (NCT01463475) has completed, involving graft-versus-host disease and acu…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: The Role of Influenza as a Trigger for Acute Myocardial Infarction: a CALIBER Study
This completed CALIBER study investigates whether influenza infection acts as a trigger for acute myocardial infarction.
-
CLINICAL_TRIALS research · 2014-11-24Clinical Trial Update: Ultrasound Beams as an Adjunct to Reperfusion Therapy in STEMI [NA]
A clinical trial update from Sakarya University investigates ultrasound beams as an adjunct to reperfusion therapy in ST-elevation myocardia…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Safety and Efficacy of Adipose Derived Regenerative Cells (ADRCs) Delivered Via the Intracoronary Route in the Treatment of Patients With ST-elevation Acute Myocardial Infarction (AMI) [Phase 2]
Phase 2 trial assessing intracoronary delivery of adipose-derived regenerative cells (ADRCs) for ST-elevation myocardial infarction evaluate…
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients [Phase 4]
A Phase 4 trial evaluated intravenous exenatide in coronary ICU patients with hyperglycemia and acute coronary syndromes, including myocardi…
-
CLINICAL_TRIALS research · 2014-11-17Clinical Trial Update: Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction
A clinical trial update discusses the effects of HTEA on heart failure due to idiopathic dilated cardiomyopathy or post-myocardial infarctio…